Glooko Inc. and Hedia ApS launched an integrated software solution in the U.K. to support people with diabetes who require advanced doses of bolus insulin. The solution combines Glooko’s diabetes ...

Washington, DC - Abciximab (ReoPro® - Lilly) bolus dosing according to antiplatelet effect appears to work as effectively as giving a single standard bolus, according to a preliminary analysis from a ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved the first smartphone application capable of initiating insulin delivery for insulin pump ...

COPENHAGEN, Denmark & PALO ALTO, Calif.--(BUSINESS WIRE)--Glooko, Inc. and Hedia today announced the launch of their interoperable solution, which combines connected care, remote patient monitoring, ...

MINNEAPOLIS--(BUSINESS WIRE)--Smiths Medical has become aware of an issue where certain Medfusion ® 3500 and 4000 syringe pumps with firmware versions listed below may not operate as expected. Due to ...

Please provide your email address to receive an email when new articles are posted on . Adults with type 1 diabetes had a higher time in range if they usually administered bolus insulin after a missed ...

Effect of target lesions selection on between-reader variability of response assessment according to RECIST 1.1. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I. This abstract ...

There’s an app for just about everything these days, and now, that even includes one to program insulin doses throughout the day—though only for a very specific cross-section of insulin pump users and ...